VP22 herpes simplex virus protein can transduce proteins into stem cells

Area of Science:

• Cell Biology
• Virology
• Stem Cell Research

Background:

• The herpes simplex virus type 1 VP22 tegument protein is known for its cell-to-cell protein translocation ability.
• Previous studies have debated VP22's translocation mechanism, suggesting artifacts, but its utility in protein delivery is established.
• The potential of VP22 to enter stem cells remained unexplored.

Purpose of the Study:

• To investigate VP22's capacity to internalize proteins into stem cells.
• To evaluate VP22 as a non-genomic tool for stem cell research and differentiation.
• To assess VP22's internalization into adult human dental pulp stem cells and mouse embryonic stem cells.

Main Methods:

• Generation of a VP22.eGFP fusion protein construct.
• Introduction of the VP22.eGFP construct into human and mouse stem cell lines.
• Microscopic evaluation of VP22.eGFP internalization within stem cells.

Main Results:

• The VP22.eGFP fusion protein was successfully internalized into both adult human dental pulp stem cells and mouse embryonic stem cells.
• Demonstrated that VP22 can indeed enter stem cells, carrying the eGFP protein with it.
• Confirmed VP22's potential as a protein delivery vehicle for stem cells.

Conclusions:

• VP22 can be internalized by stem cells, validating its use as a protein delivery system.
• This method provides a novel, non-genomic approach for delivering proteins into stem cells for research and therapeutic applications.
• Potential applications include advancing stem cell differentiation and generating induced pluripotent stem cells.